Previous research has shown promising results for treating intracranial aneurysms (IAs) with a flow redirection endoluminal device (FRED). In this systematic review and meta-analysis, we aimed to assess the safety and efficacy of this device by providing pooled estimates using the data from previous studies.
Methods
A systematic literature search of Web of Sciences, PubMed, Scopus, and Embase was performed until October 8th, 2023. After selecting the final articles, relevant data were extracted. Parameters relating to safety and efficacy were pooled using STATA software. Heterogeneity was assessed using I-squared and Cochran’s Q. Funnel plots and Egger’s regression methods were used to evaluate publication bias. Sensitivity analysis was also performed using the leave-one-out method.
Results
The data of 37 studies were used for meta-analysis. The rates of immediate adequate occlusion and complete occlusion were 0.51 (95% CI: 0.31–0.71) and 0.34 (95% CI: 0.16–0.53), respectively, while the rates of the adequate and complete occlusion at the latest follow-up were 0.90 (95% CI: 0.84–0.94) and 0.75 (95% CI: 0.65–0.84), respectively. The periprocedural complications rate was 0.04 (95% CI: 0.03–0.06), and the overall complications rate was 0.12 (95% CI: 0.09–0.15). The rate of good functional outcome was 0.99 (95% CI: 0.99–1.00) and the successful implantation rate was 1.00 (95% CI: 1.00–1.00). There was substantial heterogeneity among the reports for most of the evaluated parameters.
Conclusion
FRED had high safety and efficacy in treating IAs, as evidenced by its high occlusion and low complication rates.
Giotta LuciferoABaldonciniMBrunoN, et al.Shedding the light on the natural history of intracranial aneurysms: an updated overview. Medicina2021; 57: 742.
2.
LeeKSZhangJJNguyenV, et al.The evolution of intracranial aneurysm treatment techniques and future directions. Neurosurg Rev2022; 45: 1–25.
3.
ShinD-SCarrollCPElghareebM, et al.The evolution of flow-diverting stents for cerebral aneurysms; historical review, modern application, complications, and future direction. J Korean Neurosurg Soc2020; 63: 137–152.
4.
ZhangYZhouYYangP, et al.Comparison of the flow diverter and stent-assisted coiling in large and giant aneurysms: safety and efficacy based on a propensity score-matched analysis. Eur Radiol2016; 26: 2369–2377.
5.
ZhouGZhuY-QSuM, et al.Flow-diverting devices versus coil embolization for intracranial aneurysms: a systematic literature review and meta-analysis. World Neurosurg2016; 88: 640–645.
6.
LeeJKimDHLeeSH, et al.Stent-assisted coiling vs. flow diverter for treating blood blister-like aneurysms: a proportion meta-analysis. Clin Neuroradiol2022; 32: 889–902.
7.
WaqasMDossaniRHAlkhaldiM, et al.Flow redirection endoluminal device (FRED) for treatment of intracranial aneurysms: a systematic review. Interv Neuroradiol2022; 28: 347–357.
8.
McDougallCGDiazOBoulosA, et al.Safety and efficacy results of the Flow Redirection Endoluminal Device (FRED) stent system in the treatment of intracranial aneurysms: US pivotal trial. J Neurointerv Surg2022; 14: 577–584.
9.
KhorasanizadehMShutranMSchirmerCM, et al.North American multicenter experience with the Flow Redirection Endoluminal Device in the treatment of intracranial aneurysms. J Neurosurg2023; 138: 933–943.
10.
PierotLSpelleLBergeJ, et al.SAFE study (Safety and efficacy Analysis of FRED Embolic device in aneurysm treatment): 1-year clinical and anatomical results. J Neurointerv Surg2019; 11: 184–189.
11.
MöhlenbruchMKizilkilicOKiller-OberpfalzerM, et al.Multicenter experience with FRED Jr flow re-direction endoluminal device for intracranial aneurysms in small arteries. AJNR Am J Neuroradiol2017; 38: 1959–1965.
12.
VollherbstDLückingHDuPlessisJ, et al.The FRESH study: treatment of intracranial aneurysms with the new FRED X flow diverter with antithrombotic surface treatment technology-first multicenter experience in 161 patients. AJNR Am J Neuroradiol2023; 44: 474–480.
13.
PageMJMcKenzieJEBossuytPM, et al.The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Int J Surg2021; 88: 105906.
14.
DiazOGistTLManjarezG, et al.Treatment of 14 intracranial aneurysms with the FRED system. J Neurointerventional Surg2013.
15.
El NaamaniKSaieghFAChenC-J, et al.Treatment of cerebral aneurysms with the FRED Jr flow-diverting stent: a case series and meta-analysis. Clin Neurol Neurosurg2022; 223: 107483.
16.
DoronOMcLellanRVranicJE, et al.FRED Jr stent for acute flow diversion in ruptured cerebral aneurysms arising from small-caliber vessels: a clinical case series. Neurosurg Focus2023; 54: E6.
17.
GriessenauerCMöhlenbruchMHendrixP, et al.The FRED for cerebral aneurysms of the posterior circulation: a subgroup analysis of the EuFRED registry. AJNR Am J Neuroradiol2020; 41: 658–662.
18.
LueckingHEngelhornTLangS, et al.FRED flow diverter: a study on safety and efficacy in a consecutive group of 50 patients. AJNR Am J Neuroradiol2017; 38: 596–602.
19.
MahboobaniNRChongWHLamSSK, et al.Treatment of intracranial aneurysms with flow re-direction endoluminal device-a single centre experience with short-term follow-up results. Neurointervention2017; 12: 11–19.
20.
ManzatoLSantosRFilhoPMM, et al.Brazilian FRED registry: a prospective multicenter study for brain aneurysm treatment—the BRED study. AJNR Am J Neuroradiol2021; 42: 1822–1826.
21.
RautioRRahiMKatilaA, et al.Single-center experience with six-month follow-up of FRED Jr® flow diverters for intracranial aneurysms in small arteries. Acta Radiol2019; 60: 917–924.
22.
SayinBŞenolYCDagliogluE, et al.Endovascular treatment of challenging aneurysms with FRED Jr flow diverter stents: a single-center experience. Jpn J Radiol2023; 41: 322–334.
23.
SivasankarRShrivastavaMLimayeUS. Experience with FRED junior flow diverter in treatment of cerebral aneurysms at or distal to the circle of Willis. J Clin Neurosci2019; 69: 166–169.
24.
SuhDCSongYParkSI, et al.Flow diverter treatment using a flow Re-direction endoluminal device for unruptured intracranial vertebral artery dissecting aneurysm: single-center case series and technical considerations. Neurointervention2023; 18: 114–122.
25.
AbbasRLanMEl NaamaniK, et al.First United States multicenter experience with the new-generation FRED X surface-modified flow diversion stent: feasibility, safety, and short-term efficacy. J Neurosurg2023; 1: 1–10.
26.
LueckingHDoerflerAGoelitzP, et al.Two-to five-year follow-up of 78 patients after treatment with the flow redirection endoluminal device. Interv Neuroradiol2020; 26: 38–44.
27.
ChoiJHSimSYShinYS, et al.A single flow Re-direction endoluminal device for the treatment of large and giant anterior circulation intracranial aneurysms. Yonsei Med J2022; 63: 349–356.
28.
BrigantiFLeoneGUggaL, et al.Safety and efficacy of flow re-direction endoluminal device (FRED) in the treatment of cerebral aneurysms: a single center experience. Acta Neurochir2016; 158: 1745–1755.
29.
DrescherFWeberWBerlisA, et al.Treatment of intra-and extracranial aneurysms using the flow-redirection endoluminal device: multicenter experience and follow-up results. AJNR Am J Neuroradiol2017; 38: 105–112.
30.
GanCYangZSalahiaG, et al.A single-centre experience and literature review of flow re-directional endoluminal device (FRED) in endovascular treatment of intracranial aneurysms. Clin Radiol2021; 76: 238.e1–238.e8.
31.
GuimaraensLVivasESaldañaJ, et al. Efficacy and safety of the dual-layer flow-diverting stent (FRED) for the treatment of intracranial aneurysms. J Neurointerventional Surg. 2019; 12(5): 521–525. DOI: 10.1136/neurintsurg-2019-015371.
32.
JesserJAlberalarNDKizilkilicO, et al.Safety and efficacy of the FRED Jr Flow Re-Direction endoluminal device for intracranial aneurysms: retrospective multicenter experience with emphasis on midterm results. Front Neurol2021; 12: 722183.
33.
Killer-OberpfalzerMKocerNGriessenauerC, et al.European multicenter study for the evaluation of a dual-layer flow-diverting stent for treatment of wide-neck intracranial aneurysms: the European flow-redirection intraluminal device study. AJNR Am J Neuroradiol2018; 39: 841–847.
34.
MöhlenbruchMHerwehCJestaedtL, et al.The FRED flow-diverter stent for intracranial aneurysms: clinical study to assess safety and efficacy. AJNR Am J Neuroradiol2015; 36: 1155–1161.
35.
MöhlenbruchMSekerFÖzlükE, et al.Treatment of ruptured blister-like aneurysms with the FRED flow diverter: a multicenter experience. AJNR Am J Neuroradiol2020; 41: 2280–2284.
36.
KocerNIslakCKizilkilicO, et al.Flow Re-direction Endoluminal Device in treatment of cerebral aneurysms: initial experience with short-term follow-up results. J Neurosurg2014; 120: 1158–1171.
37.
SuyamaKNakaharaIMatsumotoS, et al.Efficacy of the Flow Re-direction Endoluminal Device for cerebral aneurysms and causes of failed deployment. Neuroradiology2022; 64: 1213–1219.
38.
TeixeiraVFBastosAMSantosRB. Endovascular therapy of 103 aneurysms in the internal Carotid artery with flow Re-direction endoluminal device. Arquivos Brasileiros de Neurocirurgia: Brazilian Neurosurgery2021; 42: e19–e23.
39.
PianoMValvassoriLLozuponeE, et al.FRED Italian registry: a multicenter experience with the flow re-direction endoluminal device for intracranial aneurysms. J Neurosurg2019; 133: 174–181.
40.
ManzatoLBSantosRBTeixeiraDO, et al.Initial experience with a flow redirection endoluminal device stent—a Brazilian multicenter study. J Stroke Cerebrovasc Dis2018; 27: e158–e164.
41.
DiazOGistTLManjarezG, et al.Treatment of 14 intracranial aneurysms with the FRED system. J Neurointerv Surg2014; 6: 614–617. DOI: 10.1136/neurintsurg-2013-010917.
42.
MöhlenbruchMAHerwehCJestaedtL, et al.The FRED flow-diverter stent for intracranial aneurysms: clinical study to assess safety and efficacy. AJNR Am J Neuroradiol2015; 36: 1155–1161. DOI: 10.3174/ajnr.A4251.
43.
GriessenauerCJThomasAJEnriquez-MarulandaA, et al.Comparison of pipeline embolization device and flow Re-direction endoluminal device flow diverters for internal Carotid artery aneurysms: a propensity score-matched cohort study. Neurosurgery2019; 85: E249–E255. DOI: 10.1093/neuros/nyy572.
44.
KandemirliSGBaltaciogluFJesserJ, et al.Flow redirection endoluminal device (FRED) with or without adjunctive coiling in treatment of very large and giant cerebral aneurysms. Clin Neuroradiol2022; 32: 471–480. DOI: 10.1007/s00062-021-01061-x.
45.
WaqasMDossaniRHAlkhaldiM, et al.Flow redirection endoluminal device (FRED) for treatment of intracranial aneurysms: a systematic review. Interv Neuroradiol2022; 28: 347–357. DOI: 10.1177/15910199211027991.
46.
JiangBPaffMColbyGP, et al.Cerebral aneurysm treatment: modern neurovascular techniques. Stroke Vasc Neurol2016; 1: 93–100. DOI: 10.1136/svn-2016-000027.
47.
RajahGNarayananSRangel-CastillaL. Update on flow diverters for the endovascular management of cerebral aneurysms. Neurosurg Focus2017; 42: E2. DOI: 10.3171/2017.3.Focus16427.
48.
CagnazzoFLefevrePHDerrazI, et al.Flow-diversion treatment for unruptured nonsaccular intracranial aneurysms of the posterior and distal anterior circulation: a meta-analysis. AJNR Am J Neuroradiol2020; 41: 134–139. DOI: 10.3174/ajnr.A6352.
49.
AbbasRLanMNaamaniKE, et al.First United States multicenter experience with the new-generation FRED X surface-modified flow diversion stent: feasibility, safety, and short-term efficacy. J Neurosurg2024; 140: 1054–1063. DOI: 10.3171/2023.7.Jns23966.
50.
KrishnaCSonigANatarajanSK, et al.The expanding realm of endovascular neurosurgery: flow diversion for cerebral aneurysm management. Methodist Debakey Cardiovasc J2014; 10: 214–219. DOI: 10.14797/mdcj-10-4-214.
51.
ZanatyMChalouhiNTjoumakarisSI, et al.Flow-diversion panacea or poison?Front Neurol2014; 5: 21. DOI: 10.3389/fneur.2014.00021.
52.
YoshizawaKKobayashiHKanekiA, et al.Poly(2-methoxyethyl acrylate) (PMEA) improves the thromboresistance of FRED flow diverters: a thrombogenic evaluation of flow diverters with human blood under flow conditions. J Neurointerv Surg2023; 15: 1001–1006. DOI: 10.1136/jnis-2022-019248.
53.
PavlovOShrivastavaAMoscote-SalazarLR, et al.The new generation double layered flow diverters for endovascular treatment of intracranial aneurysms: current status of ongoing clinical uses. Expert Rev Med Devices2021; 18: 139–144. DOI: 10.1080/17434440.2021.1879636.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
